BiotechTube
Home/axelyf/Örn Almarsson, PhD
ÖA

Örn Almarsson, PhD

CEO, Co-founder

axelyf

Therapeutic Areas

OncologyAutoimmune Diseases

axelyf Pipeline

DrugIndicationPhase
AX-004Solid Tumors (in vivo CAR-T)Pre-clinical
AX-003Autoimmune HepatitisPre-clinical

Leadership Team at axelyf

JL
John Lucas, JD, PhD
Chief Counsel, Co-founder
YX
Yan Xia, PhD
Head of Nanotechnology Formulations
DO
Daniel Omar Frímannsson, PhD
Head of Nucleic Acid Technologies and Biology
AS
Arnar Sigurðsson, PhD
Principal Scientist
View full axelyf profile